Sleep and neurodegenerative diseases

被引:31
作者
Bhatt, MH
Podder, N
Chokroverty, S
机构
[1] New York Sleep Inst, New York, NY 10016 USA
[2] St Vincent Catholic Med Ctr, Dept Neurol, New York, NY USA
[3] New Jersey Neurosci Inst JFK, Edison, NJ USA
[4] Seton Hall Univ, S Orange, NJ 07079 USA
[5] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA
关键词
neurodegenerative disease; sleep disturbance; polysomnography (PSG);
D O I
10.1055/s-2005-867072
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Sleep disturbances are common in neurodegenerative diseases. Disturbed steep can result in fatigue, irritability, morning headaches, impaired motor and cognitive skills, depression, and daytime somnolence. The major sleep complaints include: insomnia, hypersomnia, parasomnia, excessive nocturnal motor activity, circadian sleep-wake rhythm disturbance, and respiratory dysrhythmia. The pathogenetic mechanisms of sleep disturbances may be secondary to direct structural alteration of the sleep-wake generating neurons or from several other indirect mechanisms. At the biochemical level, neurodegenerative diseases may be largely classified as tauopathies, alpha-synucleinopathies, and other diseases. Overnight polysomnography (PSG) and multiple sleep latency test are the two most important diagnostic laboratory tests in the evaluation of sleep disturbances. Management of sleep disturbances is complex and is based primarily on the nature of the sleep disturbance. The clinical profiles, pathogenetic mechanisms, PSG findings, and management issues are discussed here with reference to some common neurodegenerative diseases.
引用
收藏
页码:39 / 51
页数:13
相关论文
共 101 条
[61]  
*NIH, 1991, SLEEP, V14, P169
[62]  
*NIH CONS STAT, 1983, DRUGS INS US MED PRO, V4, P1
[63]   Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease [J].
O'Suilleabhain, PE ;
Dewey, RB .
ARCHIVES OF NEUROLOGY, 2002, 59 (06) :986-989
[64]   Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases [J].
Olson, EJ ;
Boeve, BF ;
Silber, MH .
BRAIN, 2000, 123 :331-339
[65]   Daytime sleepiness and other sleep disorders in Parkinson's disease [J].
Ondo, WG ;
Vuong, KD ;
Khan, H ;
Atassi, F ;
Kwak, C ;
Jankovic, J .
NEUROLOGY, 2001, 57 (08) :1392-1396
[66]   THE DISTRIBUTION OF OLIGODENDROGLIAL INCLUSIONS IN MULTIPLE SYSTEM ATROPHY AND ITS RELEVANCE TO CLINICAL SYMPTOMATOLOGY [J].
PAPP, MI ;
LANTOS, PL .
BRAIN, 1994, 117 :235-243
[67]  
Pareja J A, 1996, Neurologia, V11, P304
[68]   Sleep disorder related to Parkinson's disease [J].
Partinen, R .
JOURNAL OF NEUROLOGY, 1997, 244 (04) :S3-S6
[69]   THE NEUROPATHOLOGIC BASIS OF DIFFERENT CLINICAL SUBGROUPS OF PARKINSONS-DISEASE [J].
PAULUS, W ;
JELLINGER, K .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1991, 50 (06) :743-755
[70]   Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease [J].
Paus, S ;
Brecht, HM ;
Köster, J ;
Seeger, G ;
Klockgether, T ;
Wüllner, U .
MOVEMENT DISORDERS, 2003, 18 (06) :659-667